Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Free triiodothyronine (substance) |
Is a |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine sodium |
Is a |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Reverse T>3< |
Is a |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triiodothyronine, free measurement |
Has measured component |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triiodothyronine, true measurement (procedure) |
Has measured component |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triiodothyronine/triiodothyronine uptake index measurement |
Has measured component |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Anti-triiodothyronine antibody |
Direct substance |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
T3 uptake measurement |
Has measured component |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tri-iodothyronine measurement, total |
Has measured component |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Serum free triiodothyronine measurement |
Has measured component |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Plasma free triiodothyronine measurement |
Has measured component |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triiodothyronine, free measurement |
Component |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triiodothyronine, true measurement (procedure) |
Component |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triiodothyronine/triiodothyronine uptake index measurement |
Component |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
T3 uptake measurement |
Component |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tri-iodothyronine measurement, total |
Component |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum free triiodothyronine measurement |
Component |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Plasma free triiodothyronine measurement |
Component |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine sodium preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levothyroxine sodium + liothyronine sodium 100mcg/25mcg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Laevothyroxine sodium + liothyronine sodium 50mcg/12.5mcg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triiodothyronine preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liotrix preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing levothyroxine sodium and liothyronine sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine poisoning of undetermined intent |
Causative agent (attribute) |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine adverse reaction |
Causative agent (attribute) |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine overdose of undetermined intent |
Causative agent (attribute) |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine sodium 20 microgram powder for solution for injection ampoule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine sodium 50 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely liothyronine sodium 5 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine sodium 25 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine sodium 10mcg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine sodium |
Is a |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental liothyronine poisoning |
Causative agent (attribute) |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional liothyronine poisoning |
Causative agent (attribute) |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Poisoning by liothyronine |
Causative agent (attribute) |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum total T3 level (procedure) |
Component |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum T3 measurement (procedure) |
Component |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Triiodothyronine measurement |
Component |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tiratricol (substance) |
Is a |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine sodium |
Is modification of (attribute) |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iodine (125-I) liothyronine |
Is modification of (attribute) |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Free triiodothyronine (substance) |
Is modification of (attribute) |
False |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levothyroxine- and liothyronine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing levothyroxine and liothyronine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine allergy |
Causative agent (attribute) |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levothyroxine and liothyronine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only liothyronine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only levothyroxine and liothyronine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental liothyronine overdose (disorder) |
Causative agent (attribute) |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine overdose |
Causative agent (attribute) |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional liothyronine overdose |
Causative agent (attribute) |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum T3 measurement (procedure) |
Component |
True |
Triiodothyronine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |